IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
714.10
-3.37 (-0.47%)
At close: Dec 5, 2025, 4:00 PM EST
710.02
-4.08 (-0.57%)
After-hours: Dec 5, 2025, 5:34 PM EST
IDEXX Laboratories Market Cap
IDEXX Laboratories has a market cap or net worth of $57.02 billion as of December 5, 2025. Its market cap has increased by 65.87% in one year.
Market Cap
57.02B
Enterprise Value
57.93B
1-Year Change
65.87%
Ranking
Category
Stock Price
$714.10
Market Cap Chart
Since December 1, 1998, IDEXX Laboratories's market cap has increased from $1.04B to $57.02B, an increase of 5,362.38%. That is a compound annual growth rate of 15.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 57.29B | 69.23% |
| Dec 31, 2024 | 33.85B | -26.56% |
| Dec 29, 2023 | 46.10B | 36.44% |
| Dec 30, 2022 | 33.79B | -39.49% |
| Dec 31, 2021 | 55.83B | 30.94% |
| Dec 31, 2020 | 42.64B | 90.35% |
| Dec 31, 2019 | 22.40B | 39.64% |
| Dec 31, 2018 | 16.04B | 17.61% |
| Dec 29, 2017 | 13.64B | 29.72% |
| Dec 30, 2016 | 10.51B | 58.51% |
| Dec 31, 2015 | 6.63B | -6.18% |
| Dec 31, 2014 | 7.07B | 28.08% |
| Dec 31, 2013 | 5.52B | 8.80% |
| Dec 31, 2012 | 5.07B | 17.41% |
| Dec 30, 2011 | 4.32B | 8.56% |
| Dec 31, 2010 | 3.98B | 27.10% |
| Dec 31, 2009 | 3.13B | 45.74% |
| Dec 31, 2008 | 2.15B | -40.14% |
| Dec 31, 2007 | 3.59B | 44.63% |
| Dec 29, 2006 | 2.48B | 7.57% |
| Dec 30, 2005 | 2.31B | 25.59% |
| Dec 31, 2004 | 1.84B | 13.89% |
| Dec 31, 2003 | 1.61B | 40.86% |
| Dec 31, 2002 | 1.15B | 19.54% |
| Dec 31, 2001 | 958.00M | 31.13% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |